Abstract
Male reproductive issues are frequently overlooked in patients of chronic myeloid leukemia (CML) on imatinib therapy. Current article describes a young man with CML on imatinib mesylate since 13 years who presented to us with painful left sided breast swelling. Mammography and fine needle aspiration cytology confirmed the diagnosis of gynaecomastia and hormone profile revealed low testosterone levels. Gynaecomastia was attributed to imatinib related hypogonadism. Gynaecomastia improved after hormone replacement therapy. Need for long term monitoring of reproductive hormones in patients of CML on imatinib therapy is emphasized in this report.
Similar content being viewed by others
References
Griffin J (2001) The biology of signal transduction inhibition: basic science to novel therapies. Semin Oncol 28:3–8
Basciani S, Mariani S, Arizzi M et al (2002) Expression of platelet-derived growth factor-A (PDGF-A), PDGF-B, and PDGF receptor-alpha and -beta during human testicular development and disease. J Clin Endocrinol Metab 87:2310–2319
Gambacorti-Passerini C, Tornaghi L, Cavagnini F et al (2003) Gynaecomastia in men with chronic myeloid leukaemia after imatinib. Lancet 361:1954–1956
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Nil.
Informed Consent
Obtained from the patient prior to publication of any material.
Ethical Clearance
The article follows the ethical guidelines as laid under Helsinki’s declaration 1976.
Rights and permissions
About this article
Cite this article
Jain, A., Varma, S., Garg, R. et al. Unilateral Gynaecomastia in a Young Man with Chronic Myeloid Leukemia. Indian J Hematol Blood Transfus 33, 448–450 (2017). https://doi.org/10.1007/s12288-016-0762-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-016-0762-z